Tag Archives: Pfizer

November 2020 Podcast Video, Financial Planning and Capital Market Update – By John Kvale …

Hello and Welcome to our November 2020 Financial Planning and Capital Market Update!

If you are too busy to read, feel free to listen as we describe our post and thoughts in friendly podcast audio format as well as Video!

Newbies –

We like to articulate our thoughts and review on a Monthly basis our Financial Planning Tips, Capital Markets and current events!

Hope you enjoy!

November Video

(YouTube)

Financial Planning Tip (s)  –

Vaccines (Times 3 and Counting) are Coming

In a great way to start the week for the past three weeks, each Monday has sported a breakthrough Vaccine announcement, first it was Pfizer, then Moderna and most recently Astrazeneca … WOW what a great way to start the week(s).

Capital Market Comments

Muted Reaction to Vaccine

Many thought the markets would have roared more post trifecta Vaccine announcements above … under the surface many companies left for dead HAVE roared, and markets have edged higher, but as mentioned most recently earlier here at current levels markets are pricing in a lot of good news already and likely are well ahead of themselves.

Have a Great November Update!

Talk to you at the end of December!

John A. Kvale CFA, CFP

Founder of J.K. Financial, Inc.

A Dallas Texas based fee only

Financial Planning Total Wealth

Management firm.

jkfinancialinc

street-cents

More Good News on the Vaccine Front, Second Possible Vaccine from Moderna … Recalling Peter Diamandis Thoughts

Early on during the onset of the virus, Peter Diamandis which we wrote about here, and here, confidently said not only would there be a vaccine but there would be multiple vaccines.

One thing Diamandis missed on his estimate would be a 50% to 75% cure rate but a cocktail of vaccines combination in order to get the cure rate much higher.

Early last week Pfizer‘s announcement of an approximate 90% cure rate was one upped early this week by Moderna.

Moderna claims almost 94% cure rate

In this press release by fellow drug research and manufacturing firm Moderna their initial trials claim a possible near 94% cure rate.

Of course these are early Stage III trials but on top of the earlier Pfizer news from last week this is very exciting.

One additional positive on the Moderna over the Pfizer is their initial thoughts are the vaccine does not have to be kept at the extreme low temperature as the Pfizer trials.

In a glass is half full fashion if Diamandis correct we should expect even more vaccines to have positive curate and to be available in the market sooner rather than later.

The Future Is Really Brighter than We Think!

Have a “Vaccine is On the Way’ Day!

John A. Kvale CFA, CFP

Founder of J.K. Financial, Inc.

A Dallas Texas based fee only

Financial Planning Total Wealth

Management firm.

jkfinancialinc

street-cents

Sun on the Horizon … Possible Vaccine … Possible Sigh of Relief

There are multiple reports out this AM that Pfizer along with a biotech partner have discovered a Vaccine that is up to 90% effective in curing infected participants.

Here is the actual press release directly from the company, for your viewing.

Being released from such a large and credible company gives this news legs. There may be disappointments, but the company mentions in the release a goal of selling the vaccine by the end of the month,

This is fast breaking news, but of course very, very good news and may have ripple effects around the world.

A large sigh of relief along with the possibility of returning to some type of normalcy may be in the cards…

Let’s hope this turns out to be accurate and available as they say….if so, we can all mark our calendars, as this may be a very important day, now and in the future!

Have a Great Day!

John A. Kvale CFA, CFP

Founder of J.K. Financial, Inc.

A Dallas Texas based fee only

Financial Planning Total Wealth

Management firm.

jkfinancialinc

street-cents